Contract award 24/00754 Refrigeration and freezer transport for medicines - FHI
Contracting authority: Norsk Helsenett SF · Norway
- Bid deadline (passed)
- Aug 2, 2024, 10:00
- Contract term
- Sep 30, 2024 – Sep 30, 2026
- Contract end
- Sep 30, 2026 (already ended)
- Procedure
- Contract award notice (CAN)
- Contract value
- NOK 40.0M
- Lots
- 2
- Bids received
- 2
- Service type
- Road transport
- Country
- Norway
- Published
- Jun 5, 2024
What does this mean?
- What stage is this tender at?
- Award: the contract has been awarded and is running.
- What does “Contract award notice (CAN)” mean?
- A contract award notice (CAN) reports the award or conclusion of a procedure.
- Until when can bids be submitted?
- The bid deadline ended on Aug 2, 2024, 10:00. Applying in this procedure is no longer possible.
- When does the contract expire?
- According to the notice the contract ends on Sep 30, 2026 (already ended). After that the service is due to be tendered again.
2 bids received.
Service
The Norwegian Institute of Public Health shall enter into a framework agreement for the refrigeration and freezer transport of vaccines, immunoglobulin and sera for large parts of the country. The aim of this procurement is to procure one supplier of medicines for the Norwegian Institute of Public Health ́s customers. FHI has approx. 4,000 customers nationwide who order medicines as needed. The medicines included in this procurement are temperature sensitive and shall mainly be distributed at 2-8°C. Some medicines require distribution at a freezing temperature (-25 to -15°C) or an ultra-freeze temperature (-90 to -60°C). The medicines must not be exposed to temperatures outside of this requirement. It is important that the quality of the medicines is maintained in the entire value chain from production to the customer. The manner in which the medicine packages are distributed depends on the geographical location in the country. The medicines can be distributed for active cooling (cooling box and/or cooling vehicle) or passive cooling (refrigeration packaging holding 2-8°C, or freezer packaging that holds -25 to -15°C, possibly -90 to -60°C). Most of the need is envisaged covered through active cooling. Furthermore there is a need for a flexible system that provides rational operation and the lowest possible cost.
Lots (2)
All lots with a service description from the notice.
- 24/00754 Refrigeration and freezer transport for medicines - FHI Sep 30, 2024 – Sep 30, 2026 NOK 40.0M Deadline Aug 2, 2024, 10:00
Show service descriptionHide service description
The Norwegian Institute of Public Health shall enter into a framework agreement for the refrigeration and freezer transport of vaccines, immunoglobulin and sera for large parts of the country. The aim of this procurement is to procure one supplier of medicines for the Norwegian Institute of Public Health ́s customers. FHI has approx. 4,000 customers nationwide who order medicines as needed. The medicines included in this procurement are temperature sensitive and shall mainly be distributed at 2-8°C. Some medicines require distribution at a freezing temperature (-25 to -15°C) or an ultra-freeze temperature (-90 to -60°C). The medicines must not be exposed to temperatures outside of this requirement. It is important that the quality of the medicines is maintained in the entire value chain from production to the customer. The manner in which the medicine packages are distributed depends on the geographical location in the country. The medicines can be distributed for active cooling (cooling box and/or cooling vehicle) or passive cooling (refrigeration packaging holding 2-8°C, or freezer packaging that holds -25 to -15°C, possibly -90 to -60°C). Most of the need is envisaged covered through active cooling. Furthermore there is a need for a flexible system that provides rational operation and the lowest possible cost.
- Contract award 24/00754 Refrigeration and freezer transport for medicines - FHI NOK 40.0M
Show service descriptionHide service description
The Norwegian Institute of Public Health shall enter into a framework agreement for the refrigeration and freezer transport of vaccines, immunoglobulin and sera for large parts of the country. The aim of this procurement is to procure one supplier of medicines for the Norwegian Institute of Public Health ́s customers in Norway. FHI has approx. 4,000 customers nationwide who order medicines as needed. The medicines included in this procurement are temperature sensitive and shall mainly be distributed at 2-8°C. Some medicines require distribution at a freezing temperature (-25 to -15°C) or an ultra-freeze temperature (-90 to -60°C). The medicines must not be exposed to temperatures outside of this requirement. It is important that the quality of the medicines is maintained in the entire value chain from production to the customer. The manner in which the medicine packages are distributed depends on the geographical location in the country. The medicines can be distributed for active cooling (cooling box and/or cooling vehicle) or passive cooling (refrigeration packaging holding 2-8°C, or freezer packaging that holds -25 to -15°C, possibly -90 to -60°C). Most of the need is envisaged covered through active cooling. Furthermore there is a need for a flexible system that provides rational operation and the lowest possible cost.
Procedure history
Official source: original notice ↗ · tender documents in the portal ↗ (the authority's link — may expire after the deadline) · Data from official tender notices (TED, German national portal). No guarantee of completeness; the official notice is binding.